Healthcare is a vital and continually evolving sector. This category covers pharmaceuticals, biotechnology, medical equipment, and healthcare services. Stay ahead with analyses of healthcare companies poised for growth amidst technological advancements and demographic shifts.
Rigel Pharmaceuticals looks cheap for a reason, but it may still be too cheap. At roughly $32.08 per share and a $592.6 million market cap on June 12, 2026, the stock screens like a mistake: a reported trailing P/E of about 1.66, positive net income, and a commercial biotech business that just posted another profitable …
Agenus is a real biotech catalyst trade, not a hidden value stock. At roughly a $144 million market cap, with Phase 2 melanoma data due at ASCO on May 31 and a first-quarter corporate update scheduled for May 11, the setup is obvious: if the botensilimab story keeps getting cleaner, the stock can move fast. …
HIMS grew revenue 59% to $2.35B in 2025 but the stock is down 52% YTD. Here’s the GLP-1 regulatory risk, the 2026 guidance, and an honest verdict on whether $15 is a buy.
Zynex is a medical technology company that specializes in the design, manufacture, and marketing of non-invasive medical devices for pain management and rehabilitation. The company was founded in 1996 and is headquartered in Lone Tree, Colorado. Zynex’s products are used by healthcare professionals and patients to manage pain, improve mobility, and enhance overall quality of …